Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 152Breast Neoplasms 40Prostatic Neoplasms 31Insulin Resistance 30Obesity 23Neoplasms 15Endometrial Neoplasms 15Pancreatic Neoplasms 14Infertility 14Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 12Anovulation 10Lung Neoplasms 9Neoplasm Metastasis 8Hyperandrogenism 8Glioblastoma 8Diabetes Mellitus 8Squamous Cell Carcinoma of Head and Neck 7Metabolic Syndrome 7Melanoma 7Rectal Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Head and Neck Neoplasms 5Brain Neoplasms 5Adenocarcinoma 5Weight Loss 4Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4

Interventions

Inositol 2relacorilant 1pembrolizumab 1maltodextrin 1Surveys and Questionnaires 1Proton Magnetic Resonance Spectroscopy 1Pioglitazone 1Metformin 1Liraglutide 1Leuprolide 1Inulin 1Glucose Tolerance Test 1Estrogens 1Continuous Positive Airway Pressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glucose Intolerance × Metformin × Clear all
NCT04892186 2024-02-20

Effects of Myo-inositol in Women With Polycystic Ovary Syndrome

University of Sao Paulo General Hospital

Phase NA Completed
60 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡